English
This article is from Journal of Pharmacology & Pharmacotherapeutics , volume 5 . Abstract Objective:: To evaluate the treatment outcome of second line drugs used in directly observed treatment, short-course (DOTS)-Plus regimen under Revised National Tuberculosis Control Program (RNTCP). Materials and Methods:: A prospective, observational study was carried out on multidrug resistant tuberculosis (MDR-TB) patients enrolled for DOTS-Plus regimen at TB and Chest Disease Department from January to December 2009. Demographic details, symptoms, sputum examination and adverse drug reactions were recorded in a case record form. Patients were followed up for 24 months. The data were analysed by Fisher's exact test and paired student's ‘t’ test. Results:: Out of 130 patients, 51 (39%) were cured, 7 (5%) completed the treatment, 25 (19%) died, 30 (23%) defaulted and 17 (13%) failure. A significant increase in body weight (P < 0.0001) was observed at the end of the 24 months. Out of 89 patients with sputum culture conversion, majority (73) turned negative within first 3 months. Female gender (P < 0.05), conversion of sputum culture from positive to negative (P < 0.0001), and radiological impro
Sign in with your free account to read, download EPUBs or listen.
Ebook · Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis. · Jain, Kalpesh, Desai, Mira, Solanki, Rajesh, Dikshit, Ram Kumar · Internet Archive